One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
A fresh look to residual risk: triglycerides, apolipoprotein B, and sweeteners
doi : 10.1093/eurheartj/ehae444
Volume 45, Issue 27, 14 July 2024
Harnessing dendritic cell metabolism for healthy ageing: reducing the risk of cardiovascular disease?
Weekly Journal Scan: sodium/glucose cotransporter 2 inhibition after myocardial infarction still in the grey area
Low-dose aspirin for the prevention of atherosclerotic cardiovascular disease
Disconnect between triglyceride reduction and cardiovascular outcomes: lessons from the PROMINENT and CLEAR Outcomes trials
Non-ST-elevation acute coronary syndromes with previous coronary artery bypass grafting: a meta-analysis of invasive vs. conservative management
Non-ST-elevation acute coronary syndromes with previous coronary artery bypass grafting: is a routine invasive strategy needed?
Chronic coronary syndromes without standard modifiable cardiovascular risk factors and outcomes: the CLARIFY registry
Improving clinical outcomes for patients with coronary artery disease despite no standard modifiable cardiovascular risk factors (SMuRF): not out of the woods yet
Discordance among apoB, non–high-density lipoprotein cholesterol, and triglycerides: implications for cardiovascular prevention
ApoB triumphs once more over LDL-C and non-HDL-C in risk prediction: ready for guidelines?
Evinacumab in homozygous familial hypercholesterolaemia: long-term safety and efficacy
ANGPTL3 as a therapeutic target for treating homozygous familial hypercholesterolaemia: a shot in the arm for evinacumab
Aerobic, resistance, or combined exercise training and its outcomes on cardiovascular risk profile in overweight or obese adults via a CardioRACE trial: a gap
First in man: blocking the false lumen backflow of aortic dissection after thoracic endovascular aortic repair by an off-the-shelf EndoSealâ„¢ system
